Alkermes (ALKS)
Alkermes Revenue Growth: 185.7%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ALKS Revenue Growth Rankings
| Overall | 98th percentile | 70 of 4358 |
| Sector | 94th percentile | 23 of 456 in Healthcare |
| Industry | 90th percentile | 1 of 10 in Drug Delivery & Accessories |
ALKS Revenue Growth Range, Past 5 Years
| Minimum | -71.64% | Dec 2009 |
| Maximum | 206.6% | Dec 2008 |
| Average | 17.44% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these ALKS related companies
ALKS News
$ALKS Mentioned more than normal on StockTwits - Currently at 12 x average daily social activity
about 10 days ago by TradeIdeasQuant
about 10 days ago by TradeIdeasQuant
$aapl out for 3.5% loss, should of put my stop in but forgot too.... $znga may be in for another leg higher $alks bad $thld consolidating
about 10 days ago by oneismany
about 10 days ago by oneismany
News related to $ALKS, currently -6.1% since open: 'Alkermes takes bigger 4Q loss after Elan deal' http://stks.co/3sPQ
about 10 days ago by TradeBot
about 10 days ago by TradeBot
Listen to $ALKS Q4 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3rwi
about 10 days ago by earningscast
about 10 days ago by earningscast
Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013
May 17, 7:00AM Business Wire
May 17, 7:00AM Business Wire
$thld $alks both holding up. Sold $thld this morning from Mondays low but looks like this one can continue.
about 11 days ago by oneismany
about 11 days ago by oneismany
@jimcramer IMO vivitrol is a joke of a drug...it's just injectable extended release naltrexone..ive sold in that market $alks
about 17 days ago by valueplayer
about 17 days ago by valueplayer
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2012
May 10, 4:00PM Business Wire
May 10, 4:00PM Business Wire
$ALKS forms bearish "Top Triangle" chart pattern. http://stks.co/3l1u
about 17 days ago by RecogniaEvents
about 17 days ago by RecogniaEvents
Alkermes’ Corporate Presentation to be Webcast at the R.W. Baird Growth Stock Conference
May 03, 4:00PM Business Wire
May 03, 4:00PM Business Wire
VIVITROL® Data to be Presented at Upcoming American Psychiatric Association Annual Meeting
May 03, 7:00AM Business Wire
May 03, 7:00AM Business Wire
Jefferies Reiterates a 'Buy' on Alkermes (ALKS); Elan Overhang Removed
Mar 22, 9:29AM Street Insider
Mar 22, 9:29AM Street Insider
Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan
Mar 13, 11:15AM Business Wire
Mar 13, 11:15AM Business Wire
$ALKS is 5.0% up since open on unusual high volume and 1.7% up since close.
about 80 days ago by TradeBot
about 80 days ago by TradeBot
$ALKS 200 Day SMA Cross - Price crossed above 200 day SMA (16.8874). Confirmed by volume.
about 80 days ago by TradeIdeasQuant
about 80 days ago by TradeIdeasQuant
Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan
Mar 08, 9:15AM Benzinga
Mar 08, 9:15AM Benzinga
Alkermes Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan
Mar 07, 4:33PM Benzinga
Mar 07, 4:33PM Benzinga
Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan
Mar 07, 4:33PM Business Wire
Mar 07, 4:33PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALKS | 16.14 | +0.19 | +1.19% | 2.092B |
| ALK | 33.96 | +0.12 | +0.35% | 2.422B |
| ALIM | 2.63 | +0.00 | +0.00% | 82.66M |
| ALGT | 64.04 | -0.21 | -0.33% | 1.222B |
| ALG | 30.55 | -0.06 | -0.20% | 362.93M |
| ALEX | 50.87 | -0.34 | -0.66% | 2.130B |
| ALE | 38.80 | +0.10 | +0.26% | 1.474B |
| ALD | 50.08 | -0.03 | -0.06% | |
| ALCO | 24.62 | -0.31 | -1.24% | 180.96M |
| ALC | 14.57 | -0.13 | -0.88% | 334.67M |
